17.3 C
New York
Friday, June 9, 2023

Make Sure You Stick With Lexicon Pharmaceuticals Inc. (LXRX). It’s Bull Time Again

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Lexicon Pharmaceuticals Inc. (LXRX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.13, or 4.48%, to $3.03. The Lexicon Pharmaceuticals Inc. has recorded 13,507 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed New Analysis Finds Sotagliflozin to Be a Cost-Effective Treatment at Commonly Accepted Willingness-to-Pay Threshold in Patients with Worsening Heart Failure.

<25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


Stocks Info

Lexicon Pharmaceuticals Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $2.90 and fluctuated between $3.0800 as its day high and $2.8600 as its day low. The current market capitalization of Lexicon Pharmaceuticals Inc. is $527.77M. A total of 1.76 million shares were traded on the day, compared to an average of 785.70K shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, LXRX has seen 23 BUY and 9 SELL insider trades, representing the acquisition of 563,608 and the disposition of 178,167 shares. Over the last 12 months, there were 28 BUYs and 9 SELLs from insiders. Insiders purchased 21,276,068 shares during that period but sold 178,167.

In the most recent transaction, Artal International S.C.A. bought 16,173,800 shares of LXRX for 2.50 per share on Aug 01. After the transaction, the Director now owns 48,433,261 company shares. In a previous transaction on Aug 01, Invus US Partners LLC bought 982,600 shares at 2.50 per share. LXRX shares that Director owns now total 5,303,814.

Among the insiders who bought shares, DEBBANE RAYMOND acquired of 982,600 shares on Aug 01 at a per-share price of $2.50. This resulted in the Director holding 5,303,814 shares of LXRX after the transaction.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for LXRX in the last 3 months, the mean price target is $6.33 with high estimates of $10.00 and low estimates of $3.00. In terms of 52-week highs and lows, LXRX has a high of $3.79 and a low of $1.31.

As of this writing, LXRX has an earnings estimate of -$0.18 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.17 per share and a lower estimate of -$0.19. The company reported an EPS of -$0.16 in the last quarter, which was -23.10% lower than expectations of -$0.13.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. LXRX’s latest balance sheet shows that the firm has $86.74M in Cash & Short Term Investments as of fiscal 2021. There were $2.28M in debt and $22.12M in liabilities at the time. Its Book Value Per Share was $0.47, while its Total Shareholder’s Equity was $113.59M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LXRX is Buy with a score of 4.33.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles